Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Agnes H Chen

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Advances in Pediatrics|July 9, 2011
Update on pediatric epilepsyAgnes H Chen
Current Pharmaceutical Biotechnology|April 22, 2011
Intrathecal enzyme replacement therapy for mucopolysaccharidosis I: translating success in animal models to patientsPatricia I Dickson, Agnes H Chen
Molecular Genetics and Metabolism|July 20, 2015
Intrathecal 2-hydroxypropyl-beta-cyclodextrin in a single patient with Niemann-Pick C1Timothy J Maarup, Agnes H Chen, Forbes D Porter, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 23, 2020
Comparison of dermatan sulfate and heparan sulfate concentrations in serum, cerebrospinal fluid and urine in patients with mucopolysaccharidosis type I receiving intravenous and intrathecal enzyme replacement therapyHaoyue Zhang, Patricia I Dickson, Ashlee R Stiles, et al.
Nature Medicine|July 29, 2024
Author Correction: Anakinra in Sanfilippo syndrome: a phase 1/2 trialLynda E Polgreen, Agnes H Chen, Youngju Pak, et al.
Nature Medicine|June 21, 2024
Anakinra in Sanfilippo syndrome: a phase 1/2 trialLynda E Polgreen, Agnes H Chen, Youngju Pak, et al.
Molecular Genetics and Metabolism|August 12, 2015
Safety of laronidase delivered into the spinal canal for treatment of cervical stenosis in mucopolysaccharidosis IPatricia I Dickson, Ilkka Kaitila, Paul Harmatz, et al.
Molecular Genetics and Metabolism|October 22, 2019
Evaluation of non-reducing end pathologic glycosaminoglycan detection method for monitoring therapeutic response to enzyme replacement therapy in human mucopolysaccharidosis IMoin U Vera, Steven Q Le, Alla Victoroff, et al.
Molecular Genetics and Metabolism|December 17, 2019
Intrathecal enzyme replacement for cognitive decline in mucopolysaccharidosis type I, a randomized, open-label, controlled pilot studyAgnes H Chen, Paul Harmatz, Igor Nestrasil, et al.
Molecular Genetics and Metabolism|July 27, 2010
Early versus late treatment of spinal cord compression with long-term intrathecal enzyme replacement therapy in canine mucopolysaccharidosis type IPatricia I Dickson, Stephen Hanson, Michael F McEntee, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Advances in Pediatrics|July 9, 2011
Update on pediatric epilepsyAgnes H Chen
Current Pharmaceutical Biotechnology|April 22, 2011
Intrathecal enzyme replacement therapy for mucopolysaccharidosis I: translating success in animal models to patientsPatricia I Dickson, Agnes H Chen
Molecular Genetics and Metabolism|July 20, 2015
Intrathecal 2-hydroxypropyl-beta-cyclodextrin in a single patient with Niemann-Pick C1Timothy J Maarup, Agnes H Chen, Forbes D Porter, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 23, 2020
Comparison of dermatan sulfate and heparan sulfate concentrations in serum, cerebrospinal fluid and urine in patients with mucopolysaccharidosis type I receiving intravenous and intrathecal enzyme replacement therapyHaoyue Zhang, Patricia I Dickson, Ashlee R Stiles, et al.
Nature Medicine|July 29, 2024
Author Correction: Anakinra in Sanfilippo syndrome: a phase 1/2 trialLynda E Polgreen, Agnes H Chen, Youngju Pak, et al.
Nature Medicine|June 21, 2024
Anakinra in Sanfilippo syndrome: a phase 1/2 trialLynda E Polgreen, Agnes H Chen, Youngju Pak, et al.
Molecular Genetics and Metabolism|August 12, 2015
Safety of laronidase delivered into the spinal canal for treatment of cervical stenosis in mucopolysaccharidosis IPatricia I Dickson, Ilkka Kaitila, Paul Harmatz, et al.
Molecular Genetics and Metabolism|October 22, 2019
Evaluation of non-reducing end pathologic glycosaminoglycan detection method for monitoring therapeutic response to enzyme replacement therapy in human mucopolysaccharidosis IMoin U Vera, Steven Q Le, Alla Victoroff, et al.
Molecular Genetics and Metabolism|December 17, 2019
Intrathecal enzyme replacement for cognitive decline in mucopolysaccharidosis type I, a randomized, open-label, controlled pilot studyAgnes H Chen, Paul Harmatz, Igor Nestrasil, et al.
Molecular Genetics and Metabolism|July 27, 2010
Early versus late treatment of spinal cord compression with long-term intrathecal enzyme replacement therapy in canine mucopolysaccharidosis type IPatricia I Dickson, Stephen Hanson, Michael F McEntee, et al.
Pageof 2